Application of CTCF snare protein in preparation of anti-uveal melanoma medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
- Publication Date
- 2017-07-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of antitumor drugs, and in particular relates to the application of a CTCF trap protein in the preparation of anti-uveal melanoma drugs. Background technique
[0002] Uveal melanoma (Uveal melanoma, UM) is the most common primary intraocular malignant tumor in adults. UM usually occurs unilaterally and unifocally, but rare cases of bilateral or multifocal tumors within the same eye occur. UM has a high degree of malignancy, which can not only lead to vision loss, but also easily metastasize to the blood, mainly to the liver, which seriously threatens the life of the patient. Due to the lack of effective early diagnosis and treatment methods, UM patients often die within one year after diagnosis. Even if the affected eye is enucleated without definite distant metastasis, the 5-year mortality rate is still as high as 17%-53%. In recent years, the incidence of melanoma has shown an increasing trend, with an annual gro...